✦ LIBER ✦

Gene delivery methods in cardiac gene therapy

✍ Scribed by Kiyotake Ishikawa; Lisa Tilemann; Kenneth Fish; Roger J. Hajjar

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 271 KB
Volume: 13
Category: Article
ISSN: 1099-498X
DOI: 10.1002/jgm.1609

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Gene therapy for the treatment of heart failure is emerging as a multidisciplinary field demonstrating advances with respect to identifying key signaling pathways, modernized vector creation and delivery technologies. Although these discoveries offer significant progress, selecting optimal methods for the vector delivery remains a key component for efficient cardiac gene therapy to validate the targets in rodent models and to test clinically relevant ones in pre‐clinical models. Although the goals of higher transduction efficiency and cardiac specificity can be achieved with several delivery methods, the invasiveness and patient safety remain unclear for clinical application. In this review, we discuss various features of the currently available vector delivery methods for cardiac gene therapy. Copyright © 2011 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Polymers in gene therapy: antisense deli

Polymers in gene therapy: antisense delivery systems

✍ Zvi H. Israel; Abraham J. Domb 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Antisense aligonucleotides can down-regulate or specifically turn off individual genes and have therefore received much attention in the era of gene therapy. While effective in vitro, delivery in vivo has been problematic. This review focusses on the progress of polymeric, non-viral methods of antis

Hepatic drug delivery and gene therapy

✍ M A Zern; T F Kresina 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Reconstituting retroviral (ReCon) vector

Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches

✍ Eva Maria Brandtner; Petra Kodajova; Juraj Hlavaty; Gerrit Jandl; Walter Tabotta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract ## Background We have previously described the generation of reconstituting retroviral (ReCon) vectors designed for cancer gene therapy using cytotoxic gene products. The unique vector structure with a promoter physically separated from the transgene allows generation of stable virus p

Gene transfer and therapy clinical trial

Gene transfer and therapy clinical trials – update. Part 2: gene delivery systems used and genes transferred

📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Part 2\*: Gene Delivery Systems Used and Genes Transferred Delivery systems Gene delivery systems are based either on physicochemical methods or on biological methods (or a combination of the two). Gene Delivery systems used in humans to date are: Physico-chemical methods Biological methods Gene gun

Gene therapy of streptozotocin-induced d

Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes

✍ France Croze; Dr Gérald J. Prud'homme 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract ## Background Despite improvements in insulin preparation and delivery, physiological normoglycemia is not easily achieved in diabetics. Therefore, there has been considerable interest in developing gene therapy approaches to supply insulin. We studied a nonviral muscle‐based method of

Gene therapy in flap survival

✍ William Waller; Jonathan Lee; Feng Zhang; William C. Lineaweaver 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Growth factors are members of a large functional group of polypeptide regulatory molecules that exert a powerful influence on all phases of wound healing and repair through interactions with specific cell surface receptors. The use of growth factors to improve wound healing and the viab